Home/Geneva Biotech/Dr. Daniel Fitzgerald
DD

Dr. Daniel Fitzgerald

CEO

Geneva Biotech

Geneva Biotech Pipeline

DrugIndicationPhase
GB-007Targets a GPCR (indication unspecified)Preclinical